TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EBOS Group Limited ( (AU:EBO) ) has issued an announcement.
EBOS Group Limited announced that 8,858 performance rights have lapsed, leaving the company with 1,480,802 performance rights on issue. This update may influence the company’s financial strategies and stakeholder interests as performance rights are a key component of employee compensation and incentive structures.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services across these sectors. The company focuses on delivering essential healthcare supplies and services to various markets in New Zealand and Australia.
Average Trading Volume: 131,457
Technical Sentiment Signal: Sell
Current Market Cap: A$5.12B
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.